| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Invex Therapeutics Ltd (AU: IXC)
IXC Technical Analysis
4
| As on 19th Jan 2026 IXC STOCK Price closed @ 0.11 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.09 & Strong Buy for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IXCSTOCK Price
| Open | 0.12 | Change | Price | % |
| High | 0.12 | 1 Day | -0.01 | -8.33 |
| Low | 0.10 | 1 Week | 0.00 | 0.00 |
| Close | 0.11 | 1 Month | -0.03 | -21.43 |
| Volume | 209963 | 1 Year | 0.04 | 57.14 |
| 52 Week High 0.16 | 52 Week Low 0.06 | ||||
AU Australia Most Active Stocks
| RML | 0.08 | 0.00% |
| LKE | 0.10 | 0.00% |
| RGL | 0.01 | % |
| AKN | 0.01 | % |
| SGQ | 0.12 | 9.09% |
| EQR | 0.11 | 10.00% |
| SVL | 0.22 | 10.00% |
| PKO | 0.01 | % |
| AAU | 0.01 | % |
| ARU | 0.28 | 0.00% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| IXC Daily Charts |
IXC Intraday Charts |
Whats New @ Bazaartrend |
IXC Free Analysis |
|
|
IXC Important Levels Intraday
| RESISTANCE | 0.15 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.13 |
| RESISTANCE | 0.12 |
| SUPPORT | 0.10 |
| SUPPORT | 0.09 |
| SUPPORT | 0.08 |
| SUPPORT | 0.07 |
IXC Forecast January 2026
| 4th UP Forecast | 0.13 |
| 3rd UP Forecast | 0.12 |
| 2nd UP Forecast | 0.12 |
| 1st UP Forecast | 0.12 |
| 1st DOWN Forecast | 0.1 |
| 2nd DOWN Forecast | 0.1 |
| 3rd DOWN Forecast | 0.1 |
| 4th DOWN Forecast | 0.09 |
IXC Weekly Forecast
| 4th UP Forecast | 0.11 |
| 3rd UP Forecast | 0.11 |
| 2nd UP Forecast | 0.11 |
| 1st UP Forecast | 0.11 |
| 1st DOWN Forecast | 0.11 |
| 2nd DOWN Forecast | 0.11 |
| 3rd DOWN Forecast | 0.11 |
| 4th DOWN Forecast | 0.11 |
IXC Forecast2026
| 4th UP Forecast | 0.34 |
| 3rd UP Forecast | 0.27 |
| 2nd UP Forecast | 0.22 |
| 1st UP Forecast | 0.18 |
| 1st DOWN Forecast | 0.04 |
| 2nd DOWN Forecast | -0 |
| 3rd DOWN Forecast | -0.05 |
| 4th DOWN Forecast | -0.12 |
Invex Therapeutics Ltd ( AU Australia Symbol : IXC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IXC Business Profile
Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial. The company was incorporated in 2019 and is based in Subiaco, Australia. Address: 38 Rowland Street, Subiaco, WA, Australia, 6008
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service